A growing trend of men self-prescribing medications for longevity, sexual health, and weight loss without consulting a physician poses significant risks, according to Dr. David Shusterman, a board-certified urologist.
Shusterman, founder of UroLongevity and Modern Urologist, expressed concern over men ordering testosterone, peptides, erectile dysfunction medications, and GLP-1 weight-loss drugs online without proper medical evaluation. This do-it-yourself approach to longevity medicine, driven by a desire for cost savings and convenience, bypasses essential medical oversight, potentially leading to dangerous outcomes.
The market for longevity and wellness is substantial, with some estimates placing it at $33 trillion. While some embrace physician-led, high-tech health monitoring, others opt for a cheaper, more accessible DIY route.
The Gray Market of Peptides
Peptides, the building blocks of proteins that regulate biological processes, are particularly concerning. While the FDA strictly regulates certain peptides for specific uses, many are sold online for "research purposes" without a prescription, circumventing purity standards and regulatory oversight. Some peptides, like BPC-157, have not been tested for human use and carry potential risks, such as potentially accelerating tumor growth in cancer patients.
Without medical supervision, individuals rely on online advice for peptide selection, dosage, and administration. This lack of professional guidance can lead to dangerous interactions with other medications, exacerbation of pre-existing conditions, and unaddressed side effects.
Testosterone and Sexual Health Medications
Testosterone replacement therapy (TRT) is intended for men with age-related testosterone decline, aiding in improving sex drive, muscle mass, energy, and mood. However, a younger demographic is increasingly seeking testosterone for aesthetic reasons, believing low levels hinder muscle development or masculine appearance. The use of anabolic steroids, synthetic forms of testosterone, is also on the rise.
In the U.S., testosterone requires a prescription, typically granted after blood tests confirm low levels. Despite these requirements, studies indicate that a significant portion of men on testosterone prescriptions may not have clinically low levels. Online services offering mail-in tests and telemedicine have made access easier, contributing to an estimated 11 million users.
Shusterman warns that testosterone therapy can be dangerous without a complete evaluation and ongoing monitoring. Potential risks include stimulating prostate growth, worsening existing prostate cancer, and increasing red blood cell production to a point where deadly blood clots could form. Furthermore, TRT can negatively impact fertility by suppressing natural testosterone production, leading to decreased sperm count, shrunken testicles, and potentially permanent effects on sperm production.
Legitimate providers should mandate bloodwork, clinical consultations, and follow-up monitoring. Shusterman advocates for a proactive, physician-led approach to men's health that is data-driven and personalized, rather than reckless experimentation.